top of page



This is a phase 3 randomised, double-blinded, placebo-controlled trial in adult subjects with moderate-to-severe AD. The trial will consist of a screening period of 2 to 6 weeks (Weeks -6/-2 to 0), an initial treatment period of 16 weeks (Weeks 0 to 16) and a maintenance treatment period of 36 weeks (Weeks 16 to 52).

Do you Qualify?

​These questions require a yes answer to qualify.​

  • Are you at least 18 years of age?

  • Have you been clinically diagnosed for at least 1 year?

  • Does your effected skin area cover at least 10% of your body?

​These questions require a no answer to qualify.​

  • Are you currently pregnant, plan to become pregnant or breastfeeding?

  • Have you ever had anaphylactic symptoms?

  • Currently suffering from any major illnesses that may require extended hospitalization?

  • In the past year have you suffered with any chronic drug or alcohol abuse?

If you think you may be eligible for this trial, please give us a call to schedule an appointment or click button below to email a request.

bottom of page